|
|
|||
| |||||||||||||||||||||||||||||||
Sexually transmitted diseases remain a major public health issue in our country. A recent report from the Institute of Medicine highlighted the impact of continuing high rates of both viral and bacterial sexually transmitted diseases and their complications with respect to morbidity, mortality, and cost. In contrast, other developed countries, such as Canada and Sweden, have virtually eliminated bacterial sexually transmitted diseases (gonorrhea, chlamydia, and syphilis) and in so doing have seen rates of pelvic inflammatory disease plummet as well. The control of these diseases has important implications that extend beyond decreasing morbidity attributable to the conditions themselves and their
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |